Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II placebo-controlled trial of Jinbei Breastcare tablets for mammary gland hyperplasia
ChiCTR-IIR-17011106Phase 2Not yet recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Dec 2016
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Jinbei Breastcare in breast hyperplasia (3 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Change in breast mass size. Planned start Dec 2016; status: not yet recruiting.
02
Drugs
Jinbei Breastcare
03
Conditions
breast hyperplasia
Beyond the preview
Go deeper on ChiCTR-IIR-17011106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17011106.